Research map: Cardiac Amyloidosis: Pathogenesis, diagnosis, and treatment

Back to the article

Papers in this map

  1. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy · Matthew J. Maurer · 2018 · 2849 citations · Cited by this paper
  2. Femoral artery pseudoaneurysm due to stent fracture in PAOD · 2026 · Related
  3. 2023 ESC Guidelines for the management of cardiomyopathies · Elena Arbelo · 2023 · 2720 citations · Cited by this paper
  4. Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease · 2026 · Related
  5. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure · Theresa A. McDonagh · 2023 · 2438 citations · Cited by this paper
  6. Ascertainment of cancer cases in the German National Cohort (NAKO): Methods and initial results · 2026 · Related
  7. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis · Julian David Gillmore · 2016 · 2086 citations · Cited by this paper
  8. The incidence, pathogen spectrum, and resistance profile of pyogenic spondylodiscitis: A nationwide retrospective evaluation of G-DRG data · 2026 · Related
  9. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases · Pablo García‐Pavía · 2021 · 1229 citations · Cited by this paper
  10. Transplacental infection: Frequency, testing, and treatment · 2026 · Related
  11. Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements · Shaji Kunnathu Kumar · 2012 · 1147 citations · Cited by this paper
  12. The proposed introduction of a prostate cancer screening program in Germany: Procedure, necessary studies before implementation, benefits, and risks · 2026 · Related
  13. Transthyretin Amyloid Cardiomyopathy · Frederick L. Ruberg · 2019 · 1123 citations · Cited by this paper
  14. Mortality data collection by local authorities compared to a cancer registry · 2026 · Related
  15. Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy · Enrica Perugini · 2005 · 989 citations · Cited by this paper
  16. Sudden hearing loss: Concert pianist with round window membrane rupture · 2026 · Related
  17. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis · Dermot M.J. Phelan · 2012 · 975 citations · Cited by this paper
  18. Companion animals and diabetes mellitus as risk factors for diphtheria due to Corynebacterium ulcerans: An analysis of data collected through the intensified diphtheria surveillance system in Germany, 2017–2022 · 2026 · Related
  19. Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy · Julian David Gillmore · 2024 · 535 citations · Cited by this paper
  20. Methamphetamine-related deaths: Medicolegal data, 2005–2025 · 2026 · Related
  21. Native T1 Mapping in Transthyretin Amyloidosis · Marianna Fontana · 2014 · 434 citations · Cited by this paper
  22. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice · Ronald M. Witteles · 2019 · 354 citations · Cited by this paper
  23. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis · Allan L. Klein · 1989 · 337 citations · Cited by this paper
  24. Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis · Mathew S. Maurer · 2023 · 335 citations · Cited by this paper
  25. Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies · Alberto Aimo · 2022 · 218 citations · Cited by this paper
  26. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy · Hartmut Schmidt · 2017 · 217 citations · Cited by this paper
  27. Management of Arrhythmias in Cardiac Amyloidosis · Shaun Giancaterino · 2020 · 209 citations · Cited by this paper
  28. Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis · Jan M. Griffin · 2021 · 205 citations · Cited by this paper
  29. SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy · Aldostefano Porcari · 2024 · 169 citations · Cited by this paper
  30. Conventional heart failure therapy in cardiac ATTR amyloidosis · Adam Ioannou · 2023 · 156 citations · Cited by this paper
  31. Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? · Fabian aus dem Siepen · 2019 · 139 citations · Cited by this paper
  32. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK) · Ali Yılmaz · 2021 · 130 citations · Cited by this paper
  33. Prevalence and clinical outcomes of transthyretin amyloidosis: a systematic review and meta‐analysis · Alexios S. Antonopoulos · 2022 · 107 citations · Cited by this paper
  34. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study · Masayuki Matsuda · 2010 · 98 citations · Cited by this paper
  35. Light chain (AL) amyloidosis: update on diagnosis and management · Michael Alan Rosenzweig · 2011 · 85 citations · Cited by this paper
  36. Amyloidosis—the Diagnosis and Treatment of an Underdiagnosed Disease · Sandra Michaela Ihne-Schubert · 2020 · 82 citations · Cited by this paper
  37. N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Troponin T Hold Diagnostic Value in Cardiac Amyloidosis · Giuseppe Vergaro · 2023 · 61 citations · Cited by this paper
  38. Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy · Daniel Philip Judge · 2025 · 57 citations · Cited by this paper
  39. Prognostic implications of pericardial and pleural effusion in patients with cardiac amyloidosis · Christina Binder · 2020 · 40 citations · Cited by this paper

Source: OpenAlex (CC0)